Sagimet Biosciences

📍 San Mateo, United States👥 21 employees💰 Last funded Apr 2024
Pharmaceutical Manufacturing🌐 sagimet.com
Website LinkedIn
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors. For more information, please visit www.sagimet.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sagimet Biosciences?
Sagimet Biosciences has 1 investors on record on gritt.io.
When did Sagimet Biosciences last raise funding?
The most recent investment in Sagimet Biosciences recorded on gritt.io was in April 2024.
What industry is Sagimet Biosciences in?
Sagimet Biosciences operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sagimet Biosciences based?
Sagimet Biosciences is headquartered in San Mateo, United States.